Skip to main content

Clinical Presentation

  • Chapter
  • First Online:
Neuropsychiatric Dysfunction in Multiple Sclerosis

Abstract

The symptoms and signs caused by MS mirror the casual and widespread distribution of the focal as well of the diffuse damage caused by inflammatory and degenerative processes of the disease. Therefore, every symptom and sign connected with a lesion of the central nervous system can appear in MS patients. However, some disturbances happen more frequently, such as optic nerve damage, pyramidal, cerebellar and somatic sensory systems involvement. Other dysfunctions (i.e., vegetative disturbances) are rare at the disease onset, but can be found in the vast majority of patients after some years of disease course. Symptoms like fatigue are difficult to be set but are undoubtedly frequent and are considered as more disabling than others by patients themselves.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Lublin FD, Reingold SC (1996) Defining the clinical course of multiple sclerosis: results of an International survey. Neurology 46:907–911

    Article  PubMed  CAS  Google Scholar 

  2. Bashir K, Whitaker JN (2002) Handbook of multiple sclerosis. Lippincot Williams & Wilkins, Philadelphia

    Google Scholar 

  3. Amato MP, Zipoli V, Goretti B et al (2006) Benign multiple sclerosis: cognitive, psychological and social aspects in a clinical cohort. J Neurol 253:1054–1059

    Article  PubMed  Google Scholar 

  4. Sayao AL, Devonshire V, Tremlett H (2007) Longitudinal follow-up of “benign” multiple sclerosis at 20 years. Neurology 68:496–500

    Article  PubMed  Google Scholar 

  5. Portaccio E, Stromillo ML, Goretti B et al (2009) Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis. Neurology 73:498–503

    Article  PubMed  CAS  Google Scholar 

  6. Coles AJ, Compston A (2004) Multiple sclerosis. Medicine 32:87–92

    Article  Google Scholar 

  7. Hyllested K (1961) Lethality, duration, and mortality of disseminated sclerosis in Denmark. Acta Psychiatr Scand 36:553–564

    Article  PubMed  CAS  Google Scholar 

  8. Leibowitz U, Alter M (1970) Clinical factors associated with increased disability in multiple sclerosis. Acta Neurol Scand 46:53–70

    Article  PubMed  CAS  Google Scholar 

  9. Poser S, Raun NE, Poser W (1982) Age at onset, initial symptomatology and the course of multiple sclerosis. Acta Neurol Scand 66:355–362

    Article  PubMed  CAS  Google Scholar 

  10. Visscher BR, Liu KS, Clark VA, Detels R, Malmgren RM, Dudley JP (1984) Onset symptoms as predictors of mortality and disability in multiple sclerosis. Acta Neurol Scand 70:321–328

    Article  PubMed  CAS  Google Scholar 

  11. Weinshenker BG, Bass B, Rice GP et al (1989) The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course. Brain 112:1419–1428

    Article  PubMed  Google Scholar 

  12. Rodriguez M, Siva A, Ward J, Stolp-Smith K, O’Brien P, Kurland L (1994) Impairment, disability, and handicap in multiple sclerosis: a population-based study in Olmsted County, Minnesota. Neurology 44:28–33

    Article  PubMed  CAS  Google Scholar 

  13. Pittock SJ, Mayr WT, McClelland RL et al (2004) Change in MS-related disability in a population-based cohort: a 10-year follow-up study. Neurology 62:51–59

    Article  PubMed  CAS  Google Scholar 

  14. Optic Neuritis Study Group (1991) The clinical profile of optic neuritis: experience of the Optic Neuritis Treatment Trial. Arch Ophtalmol 109:1673–1678

    Article  Google Scholar 

  15. Multiple Sclerosis Council for Clinical Practice Guidelines (1998) Fatigue and multiple sclerosis: Evidence-based management strategies for fatigue in multiple sclerosis. Paralyzed Veterans of America, Washington, DC

    Google Scholar 

  16. Krupp LB, Alvarez LA, LaRocca NG, Scheinberg LC (1988) Fatigue in multiple sclerosis. Arch Neurol 45:435–437

    Article  PubMed  CAS  Google Scholar 

  17. Bergamaschi R, Romani A, Versino M, Poli R, Cosi V (1997) Clinical aspects of fatigue in multiple sclerosis. Funct Neurol 12:247–251

    PubMed  CAS  Google Scholar 

  18. Fisk JD, Pontefract A, Ritvo PG, Archibald CJ, Murray TJ (1994) The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci 21:9–14

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ugo Nocentini .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Italia

About this chapter

Cite this chapter

Romano, S., Caltagirone, C., Nocentini, U. (2013). Clinical Presentation. In: Nocentini, U., Caltagirone, C., Tedeschi, G. (eds) Neuropsychiatric Dysfunction in Multiple Sclerosis. Springer, Milano. https://doi.org/10.1007/978-88-470-2676-6_3

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-2676-6_3

  • Published:

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-2675-9

  • Online ISBN: 978-88-470-2676-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics